Oral

W&H Announces Innovative Products and Sustainable Solutions as Their Key Focus at the CDS Midwinter Meeting

Retrieved on: 
Tuesday, February 14, 2023

WINDSOR, ON, Feb. 14, 2023 /PRNewswire/ - W&H Group, a leading international medical technology company, will present their latest innovations and solutions for dentists and clinicians at the Chicago Dental Society (CDS) 2023 Midwinter Meeting.

Key Points: 
  • WINDSOR, ON, Feb. 14, 2023 /PRNewswire/ - W&H Group, a leading international medical technology company, will present their latest innovations and solutions for dentists and clinicians at the Chicago Dental Society (CDS) 2023 Midwinter Meeting.
  • This national convention takes place on February 23 - February 25, 2023 at the McCormick Place West Building in downtown Chicago, IL.
  • W&H has plenty to offer when it comes to innovative products.
  • W&H's top priority is superior quality, using only high-quality materials that provide a long lifespan of its products.

PARAPRO PRESENTS THE FUTURE OF SCIENTIFIC EXCHANGE AT MAUI DERM HAWAII 2023

Retrieved on: 
Monday, February 6, 2023

CARMEL, Ind., Feb. 6, 2023 /PRNewswire/ -- ParaPRO, a specialty pharmaceutical company focused on innovative treatments for human ectoparasites, introduced Thought Leader AI – a pioneering medical education platform that enables healthcare practitioners to engage "live" with leading clinical experts on topics of public health at Maui Derm Hawaii 2023. The presentation was moderated by Maui Derm founder, Dr. George Martin, during a "Talk Story" session on January 23, 2023. Attendees were among the first to experience the educational benefits of Thought Leader AI specific to the identification, diagnosis, and treatment of scabies, a common, but underrepresented health concern.

Key Points: 
  • CARMEL, Ind., Feb. 6, 2023 /PRNewswire/ -- ParaPRO , a specialty pharmaceutical company focused on innovative treatments for human ectoparasites, introduced Thought Leader AI – a pioneering medical education platform that enables healthcare practitioners to engage "live" with leading clinical experts on topics of public health at Maui Derm Hawaii 2023.
  • The presentation was moderated by Maui Derm founder, Dr. George Martin , during a "Talk Story" session on January 23, 2023.
  • "We were excited to share Thought Leader AI with conference attendees," said Bill Culpepper III, President of ParaPRO.
  • Thought Leader AI also informs clinicians about available treatment options, including the first and only FDA-approved "complete cure" for scabies."

American Board of Oral and Maxillofacial Surgery Announces New "ABOMS Portal" Mobile App

Retrieved on: 
Wednesday, February 1, 2023

CHICAGO, Feb. 1, 2023 /PRNewswire/ -- President Bernard J. Costello, DMD, MD, FACS and the Board of the American Board of Oral and Maxillofacial Surgery (ABOMS) announce a new official mobile app, ABOMS Portal, available now in Apple's App Store & Google Play. Compatible with a range of smartphones and tablets, ABOMS Portal was created to meet the needs of both applicants for board certification and Diplomates (members).

Key Points: 
  • "We hope our new app both saves surgeons' time and facilitates their connecting with ABOMS," commented Dr. Costello.
  • Oral and maxillofacial surgeons who are in the process of applying for Board certification may utilize the secure app to:
    After a surgeon has become certified by the Board, they complete an annual Certification Maintenance process in order to affirm their ongoing competency in the field of oral and maxillofacial surgery.
  • The ABOMS Portal app now allows Diplomates to complete these modules and manage their ongoing certification on mobile devices.
  • The app will propel our mission of testing surgeon competency and assuring the public that ABOMS surgeons are their top choice when it comes to oral and maxillofacial procedures."

The American Board of Facial Cosmetic Surgery Elects New Officers and Trustees for 2023

Retrieved on: 
Thursday, January 26, 2023

MUNSTER, Ind., Jan. 26, 2023 /PRNewswire/ -- The American Board of Facial Cosmetic Surgery (ABFCS) has named new leaders and trustees for 2023, including president Faisal Quereshy, MD, DDS, FACS.

Key Points: 
  • The credentialing board announces officers and trustees, including president Faisal Quereshy, MD, DDS, FACS, who will propel the mission to uphold high standards in facial cosmetic surgery
    MUNSTER, Ind., Jan. 26, 2023 /PRNewswire/ -- The American Board of Facial Cosmetic Surgery (ABFCS) has named new leaders and trustees for 2023, including president Faisal Quereshy, MD, DDS, FACS.
  • "As president, my goal is to uphold the high standards we set for facial cosmetic surgery board certification, which ultimately help patients to locate safe and skilled surgeons.
  • With over 20 years of experience in facial cosmetic surgery, Dr. Quereshy is fellowship-trained and holds board certification from the American Board of Oral and Maxillofacial Surgery (ABOMS) and American Board of Cosmetic Surgery (ABCS) in addition to ABFCS.
  • "Through our varied background experiences, plus ongoing collaboration with one another, we help advance facial cosmetic surgery techniques and approaches.

Benchmark Education Company Celebrates Department of Defense's School Success with Benchmark Advance

Retrieved on: 
Tuesday, January 24, 2023

NEW ROCHELLE, N.Y., Jan. 24, 2023 /PRNewswire/ -- Leading educational publisher Benchmark Education Company (BEC) congratulates the fourth and eighth-grade students attending Department of Defense Education Activity (DoDEA) schools, who led the nation in scoring on the 2022 National Assessment of Educational Progress (NAEP) Reading and Mathematics Assessments. These assessments mark the first NAEP administered since the beginning of the COVID-19 global pandemic. DoDEA schools use Benchmark Advance, BEC's English Language Arts program, for their core curriculum in Grades K-5.

Key Points: 
  • NEW ROCHELLE, N.Y., Jan. 24, 2023 /PRNewswire/ -- Leading educational publisher Benchmark Education Company (BEC) congratulates the fourth and eighth-grade students attending Department of Defense Education Activity (DoDEA) schools, who led the nation in scoring on the 2022 National Assessment of Educational Progress (NAEP) Reading and Mathematics Assessments.
  • DoDEA schools use Benchmark Advance, BEC's English Language Arts program, for their core curriculum in Grades K-5.
  • DoDEA schools use Benchmark Advance, BEC's English Language Arts program, for their core curriculum in Grades K-5.
  • "We at Benchmark Education are very pleased and gratified that our resources could play a role in this impressive achievement."

Pharvaris Provides Regulatory, Clinical, and Corporate Updates

Retrieved on: 
Monday, January 9, 2023

ZUG, Switzerland, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today provided business updates and company highlights.

Key Points: 
  • ZUG, Switzerland, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today provided business updates and company highlights.
  • Pharvaris will conduct a 26-week rodent toxicology study to resolve the clinical holds in the U.S.
  • Based on the Company’s current assumptions regarding ex-U.S. regulatory status and enrollment, Pharvaris anticipates announcing top-line data from the CHAPTER-1 trial in 2H2023.
  • Pharvaris remains diligent in its operational management and is focusing on its existing clinical HAE pipeline to extend runway into 4Q2024.

Europe Compounding Pharmacies Market Report 2023: Sector to Grow by 8.25% Annually Through 2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, January 9, 2023

The European Compounding Pharmacies Market is projected to display significant growth represented by a CAGR of 8.25% during 2023-2028.

Key Points: 
  • The European Compounding Pharmacies Market is projected to display significant growth represented by a CAGR of 8.25% during 2023-2028.
  • The European Compounding Pharmacies Market was valued at USD 3314.80 Million in the year 2021 with Italy holding the largest market share.
  • The report analyses the Europe Compounding Pharmacies Market by Type (Oral, Topical, Ophthalmic, Injecs, and Others Types).
  • The Europe Compounding Pharmacies Market has been analysed by Country (United Kingdom, Germany, France, Italy, Spain, Russia, Turkey, Benelux, Nordic, and Rest of Europe).

Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast Cancer

Retrieved on: 
Tuesday, December 20, 2022

Oral paclitaxel, relative to intravenous paclitaxel, was associated with less neuropathy and was not associated with an increase in febrile neutropenia.

Key Points: 
  • Oral paclitaxel, relative to intravenous paclitaxel, was associated with less neuropathy and was not associated with an increase in febrile neutropenia.
  • Quantum Leap Healthcare Collaborative anticipates presenting these results at upcoming national meetings in Q2 of 2023.
  • “We are very pleased that the Oral Paclitaxel combination regimen graduated from this prestigious program which has brought exciting and innovative treatments to neoadjuvant breast cancer patients.
  • This study confirms our finding of less neuropathy for Oral Paclitaxel compared to intravenous paclitaxel in our metastatic breast cancer study.

Vietnam Dental Services Markets, 2017-2022 & 2023-2027: Prosthodontics, Endodontics, Cosmetic Dentistry, Periodontics Analysis, Forecasts, Competition & Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 27, 2022

Dental services cover the diagnosis, prevention, and treatment of dental problems such as diseases and infections of the mouth.

Key Points: 
  • Dental services cover the diagnosis, prevention, and treatment of dental problems such as diseases and infections of the mouth.
  • To classify and forecast the Vietnam dental services market based on service, market structure, patient type, region, and company.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Vietnam dental services market.
  • Company Profiles: Detailed analysis of the major companies present in Vietnam dental services market.

World Alzheimer's Disease Therapeutics Analysis Report 2022: 101 Active Drugs - Market Insight, Epidemiology and Pipeline Assessment by Molecule Type, Route of Administration, Pipeline Phase - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 20, 2022

The "Alzheimer's Disease Therapeutics (2022 Edition) - Market Insight, Epidemiology and Pipeline Assessment (By Molecule Type, By Route of Administration, By Pipeline Phase)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Alzheimer's Disease Therapeutics (2022 Edition) - Market Insight, Epidemiology and Pipeline Assessment (By Molecule Type, By Route of Administration, By Pipeline Phase)" report has been added to ResearchAndMarkets.com's offering.
  • Alzheimer's disease Therapeutics Pipeline Analysis has 101 active drugs undergoing several stages of clinical trials.
  • The Alzheimer's disease Therapeutics Pipeline is driven by an increasing gap of unmet need of effective therapeutics that can cure Alzheimer's disease.
  • The report analyses the Alzheimer's disease Therapeutics by Pipeline Phase (Phase I, Phase I/II, Phase II, Phase II/III, Phase III, Phase IV, Preclinical).